Skip to main content
Home
  • News
  • Politics
  • Entertainment
  • Sports
  • Technology
Back to Story
Thousands of doses of insulin are warehoused at a Kaiser warehouse in Downey, Calif., on Saturday, March 18, 2023. The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of Americans. (AP Photo/Damian Dovarganes)

Thousands of doses of insulin are warehoused at a Kaiser warehouse in Downey, Calif., on Saturday, March 18, 2023. The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of Americans. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom comments on the current high prices of insulin as he announces a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser Permanente warehouse storing thousands of Insulin drug doses in Downey, Calif., on Saturday, March 18, 2023.  (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom comments on the current high prices of insulin as he announces a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser Permanente warehouse storing thousands of Insulin drug doses in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom comments on the current high prices of insulin as he announces a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser Permanente warehouse in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom comments on the current high prices of insulin as he announces a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser Permanente warehouse in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom announces a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser Permanente warehouse in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom announces a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser Permanente warehouse in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom, left, talks to Dr. Mark Ghaly, Secretary of the California Health and Human Services Agency after announcing a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser warehouse in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

California Gov. Gavin Newsom, left, talks to Dr. Mark Ghaly, Secretary of the California Health and Human Services Agency after announcing a partnership with Civica Rx, a non-for-profit pharmaceutical company intended to manufacture insulin for the State of California's CalRx Biosimilar Insulin Initiative, at a dramatically lower cost, during a visit to a Kaiser warehouse in Downey, Calif., on Saturday, March 18, 2023. (AP Photo/Damian Dovarganes)

©2022 The Associated Press. All rights reserved.

Terms under which this site is provided. Learn more about our Privacy Policy.